
CRISPR knockout cell lines are engineered through targeted genome editing to eliminate gene function, supporting studies of cellular biology, disease mechanisms, and drug discovery.
ZNRD2 (zinc ribbon domain containing 2) encodes a zinc ribbon domain-containing protein that has been identified as an antigen recognized by a subset of anti-centromere antibodies. Its cellular function and subcellular localization have not been established based on the available information. ZNRD2 may therefore be useful as a target for investigating zinc ribbon domain-containing proteins and their potential roles in cellular processes, although its specific biological functions remain to be characterized.
JIMT-1 is a human breast cancer cell line established from the pleural effusion of a 62-year-old female patient with grade 3 invasive ductal breast carcinoma (T2N1M0) after postoperative radiation therapy. The cells carry amplification of the HER2 oncogene and have been reported to be insensitive to HER2-targeted therapies, including trastuzumab. JIMT-1 is widely used as a model for studying HER2-positive breast cancer biology, mechanisms of therapeutic resistance, and evaluation of novel anti-HER2 treatments.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.
Targeted knockout region: EExon 2
Reference Transcript: NM_006396
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use






Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?